138 related articles for article (PubMed ID: 28429233)
21. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Köllermann J; Miller K; Schrader M
Clin Cancer Res; 2006 Sep; 12(17):5040-6. PubMed ID: 16951219
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
[TBL] [Abstract][Full Text] [Related]
23. B-cell lymphoma 2 family genes show a molecular pattern of spatiotemporal heterogeneity in gynaecologic and breast cancer.
Wang J; Li S; Lin S; Fu S; Qiu L; Ding K; Liang K; Du H
Cell Prolif; 2020 Jun; 53(6):e12826. PubMed ID: 32419250
[TBL] [Abstract][Full Text] [Related]
24. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.
Martínez-Arribas F; Núñez-Villar MJ; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2003; 23(1B):565-8. PubMed ID: 12680147
[TBL] [Abstract][Full Text] [Related]
25. Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix.
Missaoui N; Hmissa S; Trabelsi A; Traoré C; Mokni M; Dante R; Frappart L
Pathol Res Pract; 2011 Jan; 207(1):37-42. PubMed ID: 21129853
[TBL] [Abstract][Full Text] [Related]
26. The prognostic significance of DAPK1 in bladder cancer.
Xie JY; Chen PC; Zhang JL; Gao ZS; Neves H; Zhang SD; Wen Q; Chen WD; Kwok HF; Lin Y
PLoS One; 2017; 12(4):e0175290. PubMed ID: 28388658
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
Ng HY; Wan TS; So CC; Chim CS
J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
[TBL] [Abstract][Full Text] [Related]
28. Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease.
Grau E; Martinez F; Orellana C; Canete A; Yañez Y; Oltra S; Noguera R; Hernandez M; Bermúdez JD; Castel V
Mol Carcinog; 2011 Mar; 50(3):153-62. PubMed ID: 21104989
[TBL] [Abstract][Full Text] [Related]
29. Hypermethylation of Death-Associated Protein Kinase (DAPK1) and its association with oral carcinogenesis - An experimental and meta-analysis study.
Jayaprakash C; Varghese VK; Bellampalli R; Radhakrishnan R; Ray S; Kabekkodu SP; Satyamoorthy K
Arch Oral Biol; 2017 Aug; 80():117-129. PubMed ID: 28412611
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of DAPK1 hypermethylation in gliomas: A site-specific analysis.
Li X; Pu J; Liu J; Chen Y; Li Y; Hou P; Shi B; Yang Q
Pathol Res Pract; 2018 Jul; 214(7):940-948. PubMed ID: 29807777
[TBL] [Abstract][Full Text] [Related]
31. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer.
Thomadaki H; Talieri M; Scorilas A
Cancer Lett; 2007 Mar; 247(1):48-55. PubMed ID: 16647810
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic dysregulation of the DAP kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in acute leukaemias.
Chim CS; Chan WW; Kwong YL
J Clin Pathol; 2008 Jul; 61(7):844-7. PubMed ID: 18587015
[TBL] [Abstract][Full Text] [Related]
34. Effect of DAPK1 gene on proliferation, migration, and invasion of carcinoma of pancreas BxPC-3 cell line.
Qin Y; Ye GX; Wu CJ; Wang S; Pan DB; Jiang JY; Fu J; Xu SQ
Int J Clin Exp Pathol; 2014; 7(11):7536-44. PubMed ID: 25550789
[TBL] [Abstract][Full Text] [Related]
35. Combinatorial chemopreventive effect of butyric acid, nicotinamide and calcium glucarate against the 7,12-dimethylbenz(a)anthracene induced mouse skin tumorigenesis attained by enhancing the induction of intrinsic apoptotic events.
Tiwari P; Sahay S; Pandey M; Qadri SS; Gupta KP
Chem Biol Interact; 2015 Jan; 226():1-11. PubMed ID: 25478867
[TBL] [Abstract][Full Text] [Related]
36. Prospecting for Breast Cancer Blood Biomarkers: Death-Associated Protein Kinase 1 (DAPK1) as a Potential Candidate.
Arko-Boham B; Owusu BA; Aryee NA; Blay RM; Owusu EDA; Tagoe EA; Adams AR; Gyasi RK; Adu-Aryee NA; Mahmood S
Dis Markers; 2020; 2020():6848703. PubMed ID: 32566040
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer sub-types display heterogeneity in gene amplification and mRNA expression of the anti-apoptotic members of BCL2 family.
Voutsadakis IA
Gene; 2023 Mar; 857():147179. PubMed ID: 36627096
[TBL] [Abstract][Full Text] [Related]
38. The Roles of the Interaction of BCL2-Antagonist/Killer 1, Apoptotic Peptidase Activating Factor 1 and Selenium in the Pathogenesis of Kashin-Beck Disease.
Wang S; Duan C; Zhang F; Wang X; Guo X
Biol Trace Elem Res; 2016 Mar; 170(1):17-24. PubMed ID: 26179084
[TBL] [Abstract][Full Text] [Related]
39. Aberrant methylation of death-associated protein kinase 1 CpG islands in myelodysplastic syndromes.
Wu X; Liu W; Tian Y; Xiao M; Wu Y; Li C
Acta Haematol; 2011; 125(4):179-85. PubMed ID: 21212658
[TBL] [Abstract][Full Text] [Related]
40. MiR-191 inhibits TNF-α induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1.
Tian X; Xu L; Wang P
Int J Clin Exp Pathol; 2015; 8(5):4933-42. PubMed ID: 26191186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]